Participants 301 331 3
chronic schizophrenic patients
Participants 924 1171 3
The combined patient population treated with 4-8 mg/day of risperidone was 1.43 times more likely to have had a clinical response on the negative symptom subscale than the combined population treated with haloperidol, perphenazine or zuclopenthixo
